Who We Are

Cell-engineering and HTS assay experts in the Bay Area
to help make
“Better Medicine, One Assay at a Time"

Multispan, Inc. is a premier cell-engineering, assay development and compound screening company focusing on drug discovery targeting GPCRs and beyond. It has created the industry’s largest, highly characterized, high quality stable cell lines expressing GPCR, kinase and other target classes. The platform uniquely empowers lead identification and optimization for developing better medicine to treat cardiovascular, metabolic, neurodegenerative, depression, inflammation, immunology and oncology diseases.

Learning Is Power

Don’t Let GPCR Tagging Bias Your Results

Harness the power of freeing your GPCR from unwanted tags using Multispan’s proprietary MultiScreen™ β-Arrestin sensor technology

HIGH THROUGHPUT SCREENING DONE RIGHT

GPCR MEMBRANE LIGAND BINDING ASSAYS THE CRITICAL ROLE OF CELL MEMBRANES

GPCR Membrane Ligand Binding Assays >>

CRISPR: A NEW BREAK IN THE PIPELINE

CRISPR Stable Cell Lines As Drug Discovery Tools

BUILDING BETTER DRUGS THE ROLE ASSAY DEVELOPMENT PLAYS IN DRUGS

The Role Assay Development Plays in Drug Discovery >>

STRATEGIES AND TOOLS TO DEVELOP A BETTER GPCR TARGETED THERAPEUTIC

>>

MULTISCREEN™ GPCR DIVISION-ARRESTED CELLS

Assay-Ready Cells For Same-Day Plate-And-Read >>

MULTISCREEN™ STABLE CELL LINES

Combining Biologically-Relevant Assays with Cell Engineering For GPCR Targets and Beyond >>


Testimonials